WHO Calls for New Measures to Identify COVID-19 Variants
MONDAY, Dec. 28, 2020 -- The World Health Organization says steps to expand genome sequencing of new variants of the coronavirus are needed as the pandemic enters its second year, the Associated Press reported.
New variants found in Britain and South Africa appear to be more contagious and have triggered new travel restrictions. WHO Director-General Tedros Adhanom Ghebreyesus said at an online news conference Monday from Geneva that "there will be setbacks and new challenges in the year ahead -- for example, new variants of COVID-19 and helping people who are tired of the pandemic continue to combat it," according to the AP.
WHO is working with scientists around the world to "better understand any and all changes to the virus" and their impact, Tedros said.
He added he wanted to "underscore the importance of increasing genomic sequencing capacity worldwide" and of sharing information with the United Nations health agency and other countries. He said that "only if countries are looking and testing effectively will you be able to pick up variants and adjust strategies to cope."
© 2021 HealthDay. All rights reserved.
Posted: December 2020
Further Support and Information on COVID-19
Read this next
FRIDAY, Jan. 15, 2021 -- In the eight weeks following the first reported U.K. death due to COVID-19, there was a decrease in referral of patients with acute heart failure, with a...
FRIDAY, Jan. 15, 2021 -- Current smokers are more likely to report symptoms suggesting a diagnosis of COVID-19, according to a study published online Jan. 6 in Thorax. Nicholas...
FRIDAY, Jan. 15, 2021 -- Roughly one-third of Americans say they will decline a COVID-19 vaccine, according to research published online Jan. 4 in Social Science &...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.